参考文献
1) Y. Goto, M. Okada, T. Kijima, et al. MA 19.01 A Phase II Study of Nivolumab: A Multicenter,Open—Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT). J Thorac Oncol 2017; 12 Suppl_2: S1883.
2) Quispel—Janssen J, van der Noort V, de Vries JF, et al. Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma. J Thorac Oncol 2018; 13: 1569-1576.
参考文献をもっと見る